Will de-extinct animals be patent eligible in the US?

Using DNA from extinct animals in conjunction with advanced technology to bring these animals back to life has been popularised by science fiction films such as “Jurassic Park”. However, developments in “de-extinction” processes have made the possibility of resurrecting these extinct animals a reality.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

USPTO rules Broad owns CRISPR animal cell editing patents

1 March 2022 Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.

Biotechnology

EPO reopens proceedings on plant and animal patentability

11 July 2017 The European Patent Office has reopened cases in which the decision depends entirely on the patentability of plants or animals obtained by an essentially biological process.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

Barnes & Thornburg reveals five new IP leaders

Former PTAB judge joins Sterne Kessler

Will de-extinct animals be patent eligible in the US?

More on this story

Editor's picks

Editor's picks

More features